Durham, North Carolina
United States
41
2017-04-06
39
2019-01-22
These are the the leading inventors for applications assigned to ARGOS THERAPEUTICS, INC.:
ARGOS THERAPEUTICS, INC. based in Durham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Mature dendritic cell compositions and methods for culturing same
#2 | 2017-03-09 β Patent 9,638,707 granted on 2017-05-02Methods of processing samples
#3 | 2016-11-10 β Patent 9,527,074 granted on 2016-12-27Processing containers
#4 | 2015-09-10 β Patent 9,879,053 granted on 2018-01-30Strain-independent amplification of pathogens and vaccines thereto
#5 | 2015-08-13 β Patent 9,409,178 granted on 2016-08-09Processing containers
#6 | 2015-08-11 β Patent 9,102,726 granted on 2015-08-11Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
#7 | 2015-03-12 β Patent 9,556,455 granted on 2017-01-31Mature dendritic cell compositions and methods for culturing same
#8 | 2015-03-05 β Patent 9,732,140 granted on 2017-08-15Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
#9 | 2014-12-11 β Patent 10,022,731 granted on 2018-07-17Centrifuge vessels with a center mound and an internal elongate tube suitable for live cell processing and associated systems and methods
#10 | 2014-01-16 β Patent 9,523,077 granted on 2016-12-20Mature dendritic cell compositions and methods for culturing same
#11 | 2013-08-22 β Patent 9,040,303 granted on 2015-05-26Apparatus for measuring volume of a fluid
#12 | 2013-04-25 β Patent 8,658,771 granted on 2014-02-25Humanized antibodies against human interferon-alpha
#13 | 2012-12-27 β Patent 10,006,901 granted on 2018-06-26CD4CD25 regulatory T cells from human blood
#14 | 2012-11-29 β Patent 8,574,901 granted on 2013-11-05Cryoconserved mature dendritic cells
#15 | 2012-10-25 β Patent 8,431,404 granted on 2013-04-30Apparatus for transfer of liquid for processing samples
#16 | 2012-09-13 β Patent 9,970,068 granted on 2018-05-15Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides
#17 | 2012-08-07 β Patent 8,236,562 granted on 2012-08-07Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells
#18 | 2012-08-02 β Patent 8,361,463 granted on 2013-01-29Humanized antibodies against human interferon-alpha
#19 | 2012-07-17 β Patent 8,222,033 granted on 2012-07-17CD4CD25T cells and Tr1-like regulatory T cells
#20 | 2012-05-10 β Patent 8,501,470 granted on 2013-08-06Dendritic cell compositions and methods
#21 | 2012-05-10 β Patent 8,603,815 granted on 2013-12-10CD4 CD25 T cells and Tr1-like regulatory T cells
#22 | 2012-01-26 β Patent 8,211,701 granted on 2012-07-03Methods for processing samples in a closed container
#23 | 2012-01-19 β Patent 8,759,505 granted on 2014-06-24Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
#24 | 2011-09-01 β Patent 8,163,885 granted on 2012-04-24Humanized antibodies against human interferon-alpha
#25 | 2011-04-07 β Patent 8,513,208 granted on 2013-08-20Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
#26 | 2010-06-03 β Patent 8,221,981 granted on 2012-07-17Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides
#27 | 2010-02-09 β Patent 7,659,119 granted on 2010-02-09Method and compositions for obtaining mature dendritic cells
#28 | 2009-12-03 β Patent 8,030,080 granted on 2011-10-04Systems and methods for processing samples in a closed container, and related devices
#29 | 2009-09-10Methods for Generating Antigen-Specific Effector T Cells
#30 | 2009-08-13 β Patent 8,672,879 granted on 2014-03-18Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
#31 | 2009-02-26 β Patent 8,153,425 granted on 2012-04-10Dendritic cell compositions and methods
#32 | 2009-01-29 β Patent 7,923,247 granted on 2011-04-12Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
#33 | 2008-12-18 β Patent 9,085,807 granted on 2015-07-21Strain-independent amplification of pathogens and vaccines thereto
#34 | 2007-11-08 β Patent 8,076,134 granted on 2011-12-13CD4+CD25β T cells and Tr1-like regulatory T cells
#35 | 2007-10-25Mrna Transfected Antigen Presenting Cells
#36 | 2007-09-13 β Patent 8,124,099 granted on 2012-02-28Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
#37 | 2007-07-19 β Patent 7,893,200 granted on 2011-02-22Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
#38 | 2007-04-12 β Patent 8,513,008 granted on 2013-08-20Mature dendritic cell compositions and methods for culturing same
#39 | 2007-04-03 β Patent 7,198,948 granted on 2007-04-03Methods and compositions for obtaining mature dendritic cells
#40 | 2006-06-08 β Patent 7,785,583 granted on 2010-08-31In situ maturation of dendritic cells
#41 | 2006-04-13 β Patent 8,822,223 granted on 2014-09-02Mature dendritic cell compositions and methods for culturing same
Also check out Argos Therapeutics, Inc.'s (Durham, United States) applicant profile with 10 patent applications submitted.
19477 β